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Background: Crohn’s disease (CD) is an inflammatory bowel disease caused by genetic and environmental factors.
More than 160 susceptibility loci have been identified for IBD, yet a large part of the genetic variance remains
unexplained. Recent studies have demonstrated genetic differences between monozygotic twins, who were long
thought to be genetically completely identical.
Results: We aimed to test if somatic mutations play a role in CD etiology by sequencing the genomes and exomes
of directly affected tissue from the bowel and blood samples of one and the blood-derived exomes of two further
monozygotic discordant twin pairs. Our goal was the identification of mutations present only in the affected twins,
pointing to novel candidates for CD susceptibility loci. We present a thorough genetic characterization of the
sequenced individuals but detected no consistent differences within the twin pairs. An estimate of the CD
susceptibility based on known CD loci however hinted at a higher mutational load in all three twin pairs compared
to 1,920 healthy individuals.
Conclusion: Somatic mosaicism does not seem to play a role in the discordance of monozygotic CD twins. Our
study constitutes the first to perform whole genome sequencing for CD twins and therefore provides a valuable
reference dataset for future studies. We present an example framework for mosaicism detection and point to the
challenges in these types of analyses.
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Crohn’s disease (CD, OMIM #266600) is a complex,
chronic inflammatory bowel disease (IBD) affecting be-
tween 0.1–16/100,000 persons worldwide, with a higher
incidence in the Western world. As a multifactorial dis-
ease, a variety of genetic and environmental factors play
a role in its etiology. Genome-wide association studies
(GWAS) and meta-analyses have so far identified a total
of 163 susceptibility loci for IBD [1], with 140 for CD.
These GWAS loci have highlighted important pathways
underlying IBD, such as immunity and autophagy. Yet,
the identified variants so far explain less than 30% of the
cumulative genetic variance for CD and it is thought
that a part of the so-called missing heritability may be* Correspondence: b.petersen@ikmb.uni-kiel.de
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unless otherwise stated.found in rare variants with larger effect sizes. Next-
generation sequencing enables the genome- and exome-
wide identification of novel variants and is therefore the
current method of choice for finding new rare suscepti-
bility loci for complex diseases. In the past 5 years re-
searchers even identified several monogenic forms of
severe early-onset colitis. For example, single mutations
in IL10 (interleukin-10 [2]) and the genes encoding for
its receptor (IL10RA and IL10RB [3]) as well as muta-
tions in XIAP (X-linked inhibitor of apoptosis protein
[4,5]) have been shown to cause severe early-onset IBD.
Monozygotic (MZ) twins have long served as a model
for the influence of environmental factors versus genetic
factors (“nature vs. nurture”), since they are believed to
be genetically identical. For example, our previously
published German epidemiologic twin study revealed
that red meat consumption, high antibiotic intake and liv-
ing abroad before time of diagnosis, especially in countriesl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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ology [6]. Moreover, our group identified several differen-
tially methylated sites in the colonic epigenome of
discordant colitis twins with functional consequences,
i.e. impact gene expression [7]. Monozygotic discordant
UC (Ulcerative colitis) twins were also shown to differ in
the bacterial composition of their gut microbiota, with
the affected twins showing less diversity than their
healthy co-twins [8]. This suggests an important link be-
tween disease and the microbiome.
In the past years it has been repeatedly shown that the
assumption of genetically identical monozygotic twins
needs to be reconsidered. Genetic differences have been
discovered between monozygotic twins [9], which can be
regarded as an extreme form of somatic mosaicism, de-
scribing the presence of two populations of cells with
different genotypes having developed from a single fertil-
ized egg as a result of postzygotic alterations of the genome
[10]. Several studies have shown discordant phenotypes be-
tween monozygotic twins resulting from genetic differ-
ences such as chromosomal mosaicism (e.g. trisomy 21
[11]) or dominant gene mutations (first shown for Van der
Woude syndrome [12]) and differences in the copy num-
ber profiles of monozygotic concordant and discordant
twin pairs were detected [13]. These findings challenge the
assumption of disease discordance in monozygotic twins
reflecting purely environmental effects. The genetic com-
parison of monozygotic twins discordant for a complex
disease has been previously proposed for finding disease-
relevant variants in a set of candidate genes [14]. During
the past years sequencing costs have dropped dramatically,
thus allowing for whole genome- and exome-wide compar-
isons of monozygotic twins, enabling the identification
of these rare genetic events without the need for prior
assumptions like focusing on certain candidate genes.
The genetic comparison of monozygotic discordant twins
therefore represents a promising possibility for finding
novel candidates for disease susceptibility that may help
explain some part of the missing heritability. Considering
the estimated human mutation rate of ~2.2 to ~2.5×10−8
per position per diploid genome [15,16], approximately
175 mutations per genome are expected per generation, in-
dicating that genetic differences between monozygotic
twins may not be so rare. However, whole genome sequen-
cing and the comparison of monozygotic twins discordant
for multiple sclerosis yielded no differences [17]. As a con-
sequence, we aimed for a higher sequencing depth (per
base coverage) in our study and included samples of the
directly affected tissue in addition to blood samples in the
sequencing to maximize our chances of detecting relevant
somatic mutations.
We here report the sequences of four genomes and
eight exomes of blood samples and bowel biopsies from
three monozygotic twin pairs discordant for CD, thestudy setup is illustrated in Figure 1. From the German
IBD twin cohort described in [18] we chose three twin
pairs based on preferably low age of onset, high current
age and the availability of blood samples and bowel bi-
opsies (Table 1). By sequencing different sample types
we were not only able to scan for differences between
the twins, but additionally search for tissue-specific
variants in the bowel tissue directly affected by the in-
flammation of CD. This is to our knowledge the first
characterization of genomes and exomes of monozygotic
twins discordant for Crohn’s disease.
All three twin pairs were female and of German ances-
try and co-twins grew up together. In all affected twins,
the disease showed ileocaecal localization and the diag-
nosis was confirmed by both endoscopy and histopath-
ology. The first twin pair (TP1) was 63 years old at time
of recruitment with an age-of-onset of 45 in the affected
individual. The patient did not suffer from fistula or
stenosis but presented with arthritis as an extraintestinal
manifestation. So far, no surgery was necessary and
flares occurred approximately once a year with few hos-
pitalizations. The second twin pair (TP2) was 45 years
old at time of recruitment. The affected twin had been
suffering from Crohn’s disease since the age of 19 and
presented with anal fistula to the skin and arthritis as an
extraintestinal manifestation. She underwent emergency
gut surgery due to ileal perforation in the ninth year of
disease. The patient was hospitalized approximately once
per year since disease onset and has in total spent more
than 6 months in the hospital. Since surgery, she has no
longer been suffering from regular flares. The third twin
pair (TP3) was 32 years old at time of first participation
in the study and showed the earliest age-of-onset of the
three twin pairs with only twelve years. The patient pre-
sented with fistula (both anal and inguinal) and had been
admitted to the hospital less than every two years for a
total of one to three months since disease onset. The
frequency of flares was one to three per year with few
hospital stays necessary. In all twin pairs, the healthy
twin showed no signs of intestinal inflammation.
Results
For TP1, four genomes and four exomes of blood-
derived DNA as well as DNA from bowel biopsies were
sequenced. From TP2 and TP3, blood samples of both
twins were exome sequenced, resulting in a total of four
genomes and eight exomes from three twin pairs. All
samples were sequenced to a minimum average coverage
of 36× (Table 1). In total, more than 500Gb of sequences
were uniquely aligned for the four genomes, resulting in
coverage of more than 93% of the whole human genome
reference. This value represents the upper limit of what
can possibly be covered, since the female human gen-
ome reference hg19 (excluding chromosome Y) that was
Figure 1 Overview of study setup involving exome and genome sequencing for three monozygotic twin pairs (TP1-3) discordant for
Crohn’s disease.
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are also consistent with previously reported genomes
[15,19]. For the exomes, on average over 96% of the tar-
geted regions were covered. The genomes yielded a
mean value of 3,063,616 variants, which is in agreement
with an estimated human nucleotide diversity of 0.1%
[20]. The expected transition/transversion (Ti/Tv) ratio
for genome-wide single nucleotide variants (SNVs) is 2.1
and approximately 2.8 for exons [21] and can be used
as an indicator for the quality of SNV detection. Our
genome-wide SNVs accurately matched these values,
while those for exome-wide SNVs ranged between 2.6
and 2.8, and were therefore between the recommended
values for genomes and exomes. This is to be expected,
as the enriched targets do not exclusively consist of
exons, but to a large part also include additional regions
such as the untranslated regions (UTRs) of numerous
genes. As an additional quality control for our variant
calls, we calculated the SNV concordance in pairwise
comparisons for all twin pairs. Greater than 93% con-
cordance was achieved for the genomes of TP1 and
greater than 99% for the corresponding HiSeq exomes.
The overlapping genome and exome SNVs were more
than 93% concordant. The exomes of TP2 and TP3
showed more than 96% pairwise concordance. These re-
sults additionally confirmed the monozygosity of all ana-
lyzed twin pairs and suggest an adequate data quality.
Detailed numbers for the concordance in all datasets are
illustrated in Additional file 1: Figure S1. The ratio of
nonsynonymous to synonymous changes among rare
(frequency <0.5%) variants typically ranges between 1
and 2, and among common variants between 0.5 and 1.5
[22]. For a typical whole genome resequencing project
the estimated ratio is between 0.8 and 1.0 [21]. Our ob-
served nonsynonymous to synonymous ratios between
0.8 and 0.9 (Table 1) confirm these observations. The
numbers of non-frameshift and frameshift InDels and
nonsense SNVs detected in our study average belowthose of the 1000 genomes project (estimation of 130 to
178 non-frameshift and 192 to 280 frameshift InDels
and 67 to 100 nonsense SNVs) while we detected a
slightly higher number of splice-site variants (28 to 45
splice-site variants estimated). These deviations may be
attributable to differences in data generation or more
stringent variant calling. We estimated the number of
potentially deleterious and disease-related variants in
our dataset by computing the number of variants classified
as disease-causing (DM) in the Human Gene Mutation
Database (HGMD Professional, version 2013.3). Even a
healthy genome contains between 50 and 100 DM variants
[21] and we observed no excess in our dataset. We de-
tected between 630 and 767 missense variants predicted to
be “deleterious” by SIFT [23] or “probably damaging” by
PolyPhen2 [24] in each of our genomes and exomes.
Missense variants with a Grantham score above 100,
representing amino acid changes defined as moderately
radical (>100) and radical (>150 [25]) have a higher likeli-
hood of clinical consequences. We found 17 to 18% of all
missense variants to fall into this category. A high PhyloP
value illustrates a strong evolutionary conservation of the
affected genomic position and most pathogenic missense
variants have been shown to have a PhyloP score above
2.5 [26]. With approximately 7,700 highly conserved vari-
ants the genomes only display approximately four times
the number found in the exomes, despite magnitude dif-
ferences in total size. This is attributable to the higher
conservation of exonic regions. As even the genome of a
healthy person contains at least 100 loss-of-function vari-
ants [27], it is difficult to establish a connection between
the large number of potentially deleterious variants and a
higher susceptibility to CD.
For the reliable detection of differences between co-
twins we used three tools in parallel and separately evalu-
ated the results to achieve the highest possible sensitivity
and hence lowest false-negative ratio: SomaticSniper [28]
employs a Bayesian comparison of the genotype likelihoods
Table 1 Description of the three twin pairs and corresponding sequencing statistics
Twin pair 1 Twin pair 2 Twin pair 3
Sex Female Female Female
Age of onset in affected twin 45 19 12
Year of birth 1944 1962 1974
Recruited 2007 2007 2006


























Gb coverage 126.70 124.02 143.82 110.28 3.44 3.16 2.47 3.50 3.33 3.29 2.86 2.21
Average coverage 41.92 41.03 47.58 36.49 55.36 50.83 39.81 56.34 72.29 71.58 62.22 47.88
% of genome/exome covered:
≥ 1× 93.12 93.05 93.04 93.03 97.10 97.17 96.25 96.97 97.28 97.16 96.64 95.36
≥ 8× 90.46 88.95 88.77 90.49 91.48 90.72 89.11 91.82 90.13 89.87 88.91 85.25
≥ 20× 73.29 65.11 67.26 80.82 83.37 79.47 76.78 84.72 80.39 79.87 78.27 71.02
Total number of variants 3,064,772 3,053,010 3,055,001 3,081,680 44,890 44,357 44,928 44,920 29,180 28,985 28,407 27,465
Ti/Tv ratio 2.1 2.1 2.1 2.1 2.6 2.6 2.6 2.6 2.7 2.7 2.7 2.8
NS/S ratio 0.9 0.9 0.9 0.9 0.8 0.8 0.8 0.8 0.9 0.9 0.9 0.9
Total number of SNVs 2,894,614 2,878,835 2,877,807 2,911,350 44,377 43,846 44,426 44,406 28,663 28,542 27,947 27,185
Total number of InDels 170,158 174,175 177,194 170,330 514 512 503 515 517 443 460 280
Synonymous SNVs 9,655 9,630 9,658 9,625 10,168 10,046 10,163 10,205 8,977 8,920 8,678 8,457
Missense SNVs 8,443 8,414 8,425 8,413 8,600 8,488 8,588 8,618 7,668 7,639 7,562 7,369
Nonsense SNVs 64 66 63 65 57 56 57 57 56 58 58 54
Non-frameshift InDels 77 76 78 78 208 208 201 209 205 182 169 111
Frameshift InDels 53 48 54 48 144 142 141 143 296 246 273 162
Stopgain InDels 0 0 0 0 3 3 3 3 0 0 0 0
Splice-site variants 55 56 56 58 96 96 96 98 45 45 49 34
Variants in UTR 208,685 207,740 207,924 209,726 23,714 23,446 23,770 23,685 1,253 1,241 1,195 1,143
Intronic variants 956,711 953,878 954,959 962,132 1,659 1,635 1,667 1,659 10,154 10,127 9,836 9,573
Intergenic variants 1,881,029 1,873,102 1,873,784 1,891,535 242 238 243 244 526 527 587 562



















Table 1 Description of the three twin pairs and corresponding sequencing statistics (Continued)
Damaging SNV predictions
HGMD 57 59 55 59 61 61 61 61 44 43 40 41
SIFT 697 689 697 695 685 686 683 689 674 670 645 630
PolyPhen2 734 731 728 733 765 764 755 767 653 651 648 639
Grantham score 1,442 1,437 1,445 1,439 1,496 1,499 1,477 1,501 1,356 1,355 1,372 1,327
PhyloP 7,753 7,728 7,730 7,757 1,854 1,855 1,837 1,859 1,968 1,964 1,957 1,892
Coverage and variant calls for exomes refer to the corresponding exome target. Ti/Tv ratio: transition/transversion ratio of SNVs; NS/S ratio: nonsynonymous to synonymous ratio of SNVs; SNVs not in dbSNP132 for TP1
(hg19) and dbSNP130 for TP2 and TP3 (hg18) are defined as novel. SNVs predicted to be damaging: “DM” in HGMD (Human Gene Mutation Database Professional, version 2013.3), missense SNVs called as “deleterious”



















Petersen et al. BMC Genomics 2014, 15:564 Page 6 of 11
http://www.biomedcentral.com/1471-2164/15/564while VarScan [29] uses heuristic methods to test the
significance of allele frequency differences using Fisher’s
Exact Test. They both involve a direct comparison of
the alignments of different samples to detect differences
and were originally designed for tumor and normal
pairs. The third tool pibase [30], previously released by
our group, interrogates positions of interest in the
alignment and performs a Fisher’s exact test incorporat-
ing different quality filters based on e.g. mapping qual-
ity, base quality and number of unique start points to
determine the probability of differences. For TP1, with
exome and genome data from blood samples as well as
bowel biopsies available, we were able to scan for dif-
ferences between the twins as well as tissue-specific
mutations. For the exome data from the blood samples
of TP2 and TP3, the comparison between affected and
healthy twin was carried out accordingly. The comparison
of the top 100 calls from the three methods showed only
marginal overlap, confirming the results of previous studies
[31]. A maximum of two variants were called by all three,
the highest overlap was found between SomaticSniper and
VarScan with four to 25 shared variants (Additional file 1:
Figure S2 a-c). Somatic mutations with a p-value below
0.01 from Fisher’s exact test or in case of SomaticSniper
a somatic score above 100, were manually checked
through inspection of the alignments using the Integra-
tive Genomics Viewer (IGV [32]). The majority of calls
was already excluded at this stage. The false-positives
were either attributable to false-negative calls in the
healthy sample, mostly due to low quality alignments or
low coverage, or they were caused by false-positive calls
in the diseased sample, often due to alignment artifacts
caused by nearby InDels. One example is shown in Figure 2
where a somatic mutation in the biopsy compared to
the blood sample of the affected twin was called by
SomaticSniper and VarScan on chromosome 3 at pos-
ition 55,862,522 marked as “SNV2” in the intronic region
of ERC2. The visual assessment of this region showed the
occurrence of a second SNV and an insertion nearby in
the alignments of the two samples. Manual realignment
of reads containing one of the three variants each con-
firmed that the reads could all be aligned by introducing
a 19 bp insertion (‘CGCAGCAGGGGCAGCAGGG’)
compared to the reference sequence, confirming identical
DNA sequences in both samples. For the pairwise com-
parisons in TP1, where four genomes and exomes were
sequenced, the two samples not involved in the compari-
son were always available for further clarification, e.g. a
variant detected in the blood sample of the CD twin and
not in the blood sample of the healthy twin is highly un-
likely to be a somatic mutation if we can also detect it in
the bowel biopsy of the healthy twin. We were add-
itionally able to cross-check exonic mutations from the
exomes and genomes of the same samples. In total wevisually inspected more than 2,200 potential somatic muta-
tions for all three twin pairs (Additional file 1: Table S2).
Following these steps, we excluded all candidates for TP1
and selected 15 variants from TP2 and TP3 for validation
through Sanger sequencing. However, none of the variants
could be confirmed as discordant as they were found to be
either false-positive calls in one sample or present in both
samples.
For TP1 we also performed differential copy number
variation analysis. The genomes showed 128 CNVs po-
tentially present only in the affected twin after filtering.
These were visually inspected in the alignments and
compared to the CNVs called for the exomes. The pair-
wise comparison of exome CNVs from blood samples
did not show any region above the filtering cutoffs while
the biopsies showed a deletion on chromosome 11 for
the exome data. However, this region does not show up
in the comparison of blood and biopsy of either twin,
nor does it show up in the blood comparison or the gen-
omic CNVs, and there are not sufficient SNVs to sup-
port a loss of heterozygosity (LOH) in the region.
Therefore, none of the observed potential copy number
losses or gains differing between twins or tissues showed
sufficient support to be deemed of interest for follow-up
analysis.
We estimated the genetic susceptibility of the twin
pairs to CD by computing the genotypes of the ge-
nomes of TP1 and also, where available, those from
the exomes of TP2 and TP3 at the identified CD risk loci
([1] Additional file 1: Table S3). The overall risk, repre-
sented by the summed up logarithmic odds ratios for the
133 CD risk alleles present in the twins, showed a higher
mutation load in the three twin pairs in direct compari-
son to the distribution of the calculated overall risk of
1,920 healthy individuals genotyped on the Immunochip
(Figure 3 a-c). This indicates that although genetic differ-
ences between the co-twins were not detected, a certain
proportion of genetic susceptibility may still play a role
for the development of CD in the affected twins and the
discordance between twins is most likely attributable to
environmental factors.
Discussion
We here report the first whole genome and exome se-
quences of MZ twin pairs discordant for CD. We de-
tected no reproducible differences within the twin pairs.
Based on the good data quality and a high genotype con-
cordance between samples and different methods, our
data provided a solid foundation for the detection of
somatic mutations between the co-twins. The low over-
lap between the three used tools for the detection of dif-
ferences argues against the presence of somatic mutations.
We therefore assume a high probability of the analyzed
genomes and exomes being truly genetically identical.
Figure 2 Screenshot from IGV at a position called as a significant difference between the blood sample and biopsy exomes of the
affected twin from TP1 (SNV2). The alignment shows another SNV (SNV1) and an insertion nearby. Realignment of one read each shows
identical alignability to the reference by introduction of a 19 bp insertion.
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ough analysis methods, the probability remains that we
overlooked existing differences. The samples sequenced
for TP1 consisted of blood samples as well as bowel biop-
sies for genomes and exomes. We decided on this ap-
proach since it allows for an exceptionally thorough lookFigure 3 Sum of odds ratios for the three twin pairs at 133 susceptib
vertical line represents the value of the respective twin pair. a: Calculated f
genotypes were available for TP2 and TP3, respectively.at the genetic data and offers the unique possibility of
identifying tissue-specific somatic mosaicisms, especially
in the tissue of interest for the particular disease. But the
analysis of biopsy-derived DNA also involved a certain
trade-off. The low yield of DNA extracted from a single
biopsy required the pooling of DNA from several biopsiesility loci for CD and IBD compared to 1920 healthy controls. The
or all 133 SNVs in TP1. b and c: Calculated for 44 and 40 SNVs where
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been present in all biopsies used for sequencing and it is
unlikely that we would have been able to detect mutations
present in only a small fraction of the sequenced samples
and if so, validation through Sanger sequencing would
present another challenge. On the other hand, mutations
present only in some regions of the bowel would be rather
unlikely to have an effect on the development of Crohn’s
disease. In the future, this problem may best be handled
through the application of single cell sequencing [33],
where the resulting genome truly represents the genome
of a single cell and not the pool of what may possibly be
several mosaics. This also applies to tumor genome rese-
quencing where similar single-cell-based approaches are
currently envisioned. For TP1, the biopsies were taken
from affected regions in the colon, however the primarily
ileocaecal disease localization in the affected twin may be
an issue for finding somatic mutations. It is questionable if
the affected twin from pair 1 represents an ideal candidate
for a genetic study. With an age of onset of 45, only a few
short hospital stays and no surgery needed so far, the
course of the disease is comparatively mild and hence the
genetic contribution may be low. However, the availability
of the bowel biopsies from both twins considerably limited
the number of possible twin pairs. In turn, we chose a
lower age of onset and more severe disease course for TP2
and TP3, for whom only blood samples were available and
subjected to sequencing. The three twin pairs chosen for
this project therefore constitute the best possible trade-off
between sample suitability and availability.
The theoretical probability that an offspring of a dia-
mniotic MZ twin father carries a germline mutation that
can be detected by allele-specific PCR in a sperm sample
of their biological father, but not of his twin brother was
defined at approximately 83% [34]. This thought experi-
ment assumes circumstances clearly differing from the
situation with our three female twin pairs, but nonethe-
less this estimated value may give an idea of the prob-
ability of finding differences in our twin pairs. Essentially,
an experimental test of this theory in one male twin pair
did detect five differences in genomes from sperm-derived
DNA [35]. Only one of these SNVs however was also de-
tected in the according blood samples, suggesting much
variation in the detectable number of differences, also de-
pending on the tissue type sequenced. In this study we
focused solely on the detection of genetic differences
between MZ twins for finding novel candidates for CD
susceptibility. However, several other mechanisms may
also be involved in disease discordance. Bowel biopsies of
MZ twins discordant for ulcerative colitis, from the same
cohort as in this study, were shown to differ in their DNA
methylation patterns and exhibit differential gene ex-
pression [7], suggesting a role in disease development
and yielding several novel candidate genes. For psoriasis,another disease involving chronic inflammation, DNA
methylation and gene expression data in MZ discordant
twins showed no differences between co-twins when ana-
lyzed separately. However, a combined analysis identified
genes where differences in DNA methylation between un-
affected and affected twins correlated with differences in
gene expression [36] and hereby identified several known
and novel susceptibility genes. In contrast, sequencing of
the genomes of one twin pair and transcriptome sequen-
cing, SNP chip and methylation chip data of three discord-
ant twin pairs revealed no differences between co-twins
discordant for multiple sclerosis [17].
Conclusions
Our results are in accordance with previously published
results and suggest that it is unlikely that somatic muta-
tions have a substantial impact on the development of
Crohn’s disease, yet we cannot completely exclude the
possibility of having missed existing somatic mutations
in the three twin pairs examined. Moreover, our study
provides an analytical example framework to perform
mosaicism detection and hints at potential weaknesses
of existing variant detection tools. In the future, system-
atic transcriptome, methylome and microbiome analyses
on MZ discordant twins using Next Generation Sequen-
cing technologies are the way forward and can further
elucidate the role of differential gene expression and dif-




The monozygotic twin pairs sequenced in this study were
recruited as part of the cohort described in Spehlmann
et al. [18]. The study setup was approved by the Bioethical
Committee of the University of Kiel. All patients gave writ-
ten informed consent before data and biomaterials were
collected. Biopsies were taken endoscopically from a de-
fined area of the colon, and immediately snap-frozen in li-
quid nitrogen. DNA was extracted from the biopsies using
the QIAamp Tissue DNA preparation kit (Qiagen, Hilden,
Germany). Genomic DNA was extracted from blood using
the Invitek kit (Invitek, Berlin, Germany) and each DNA
sample was evaluated by gel electrophoresis for the pres-
ence of high-molecular weight DNA.
Sequencing
The four genomes of TP1 were sequenced on an Applied
Biosystems SOLiD v.3+ on four to five whole slides per
sample using a combination of paired-end (50 and 25 or
35 bp read length) and 1 kb insert mate-pair libraries (50
and 35 bp read length) (Additional file 1: Table S1). The
four exomes of TP1 were enriched using Illumina’s TruSeq
exome kit (Illumina, San Diego, CA, USA) according to
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one lane of an Illumina HiSeq2000 with 100 bp paired-end
reads. The four exomes of TP2 and TP3 were enriched
using the SureSelect Human All Exon kit v.2 (Agilent
Technologies, Santa Clara, CA, USA) and sequenced with
50 and 35 bp paired-end reads on one quarter slide of the
SOLiD v3+ each.
Mapping and variant calling
The SOLiD reads were mapped using ABI’s Bioscope v1.2
software, for the Illumina HiSeq data we used BWA [37].
Further processing involved formatting with SAMtools
[38] duplicate removal, local realignment around InDels,
base quality score recalibration and coverage calculation
using Picard (http://picard.sourceforge.net), BEDtools [39]
and GATK [40], which was also used for variant detection.
We applied our in-house tool snpActs (http://snpacts.
ikmb.uni-kiel.de/) for variant annotation, computation of
concordance and their illustration in Venn diagrams.
Detection of somatic mutations
For the genomes and exomes of TP1, three pairwise
comparisons were carried out: CD biopsy vs. CD blood,
CD blood vs. healthy blood and CD biopsy vs. healthy
biopsy. We used SomaticSniper v0.7.4 [28] for all ge-
nomes and exomes, filtering reads with mapping quality
below 10. The somatic score calculated by SomaticSni-
per represents the phred-scaled probability that the two
genotypes are different and ranges between 0 and 255.
We manually checked those with a somatic score above
100 (representing a probability of 1-10(100/-10) for a dif-
ference between samples). For the comparison using
pibase v.1.4.5 [30] we used all variant positions called for
the respective exomes, while for the genomes we re-
duced the number of query positions by using the vari-
ants not called in all four and not called in both biopsy
or blood samples and with a maximum 1000 genomes
frequency of 20%. We then used pibase_bamref to query
the positions in the bam files, pibase_consensus to
compute the genotypes and pibase_fisherdiff for the
pairwise comparison of samples using a Fisher’s exact
test. All variants with p-values below 0.01 were manu-
ally inspected. The third tool for the detection of dif-
ferences was VarScan v2.3.2. [29]. However, the results
for the genome data indicated problems with the com-
patibility with SOLiD data mapped with BioScope, most
likely due to the library types used, including different
read lengths and insert sizes. We therefore excluded the
VarScan results for the genomes. For the remaining
comparisons we visually inspected somatic SNVs with
p-values below 0.01 and no occurrence of the variant allele
in the second sample. Additional file 1: Table S2 summa-
rizes the number of inspected sites for all comparisons
with the three tools and the concordances between thethree methods are shown as Venn diagrams in Additional
file 1: Figure S2 a-c.
CNVs in the genome data were detected using
RDXplorer [41] and filtered with a customized pipeline.
We narrowed down our selection the CNVs called in
both samples of the affected twin but not in those of the
healthy twin to find differences. We used BEDtools to de-
tect CNVs reciprocally overlapping by at least 90% in
the blood sample and biopsy of the affected (18,680
CNVs remaining), but not overlapping CNVs in the two
samples from the healthy twin (1,235 remaining). We re-
moved likely false-positive copy number loss calls locat-
ing to regions often experiencing low coverage due to
mappability issues in non-unique genomic regions in-
cluded in the “Mappability or Uniqueness of Reference
Genome from ENCODE” track from UCSC [42] calcu-
lated for the uniqueness of the reference in 35 bp
Windows (ftp://hgdownload.soe.ucsc.edu/goldenPath/hg19/
encodeDCC/wgEncodeMapability/). For the remaining 128
CNVs potentially present only in the affected twin we
added annotations from CCDS genes and known CNVs
from the Database of Genomic Variants (DGV [43])
followed by manual inspection in the alignments in the
Integrative Genomics Viewer (IGV [32]). For the CNVs
in the exome data of TP1 we applied the in-house
CNV calling pipeline, clinCNV (S. Ossowski, personal
communication). This tool leverages the depth of cover-
age from multiple samples, and from paired samples (e.g.
normal/tumor pairs) to identify copy number variable
regions. Potential CNV regions were filtered based on
number of 100 bp windows per region, percentage of
windows with a positive loss or gain call, and average
ratio against 58 healthy background control samples
(20 baits, 80% support, somatic ratio <0.62 for losses
or >1.38 for gains).
Estimation of CD susceptibility
The susceptibility estimation was based on data from the
Immunochip project of the International IBD Genetics
Consortium (IIBDGC; http://www.ibdgenetics.org). The
genotypes of 1,920 healthy German controls were extracted
from the data set release 5 (MSControl_QC_Version3)
and filtered down to the SNVs associated with CD by
Jostins el al. [1] using the PLINK software [44]. The ori-
ginal 163 SNVs displaying association with CD, UC and
IBD were based on release 4 of the data set. We ex-
cluded those exclusively associated with UC and another
seven were removed in release 5 due to quality control
filtering. For our dataset, the remaining 133 SNVs were
used for TP1, of which 27 were exclusively associated
with CD. For TP2 and TP3 the control dataset was re-
duced to those SNVs where genotypes were available
from the exomes, resulting in a total of 44 and 40 SNVs,
respectively (Additional file 1: Table S3). The risk alleles
Petersen et al. BMC Genomics 2014, 15:564 Page 10 of 11
http://www.biomedcentral.com/1471-2164/15/564and odds ratios (OR) calculated by Jostins et al. were
used for the allelic carriership based model: For each oc-
curring risk allele in the twin pairs and the controls the
logarithmic ORs were summed up. The distribution of
the sum was plotted using R scripts [45], and the particu-
lar location for the analyzed twin pair was marked.
Availability of supporting data
The genome and exome sequencing data supporting the
results of this article are available upon request.
Additional file
Additional file 1: Supplementary information: A: clinical history of
the three monozygotic discordant twin pairs B: Supplementary
Figures S1-S2 C: Supplementary Tables S1-S3.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
B-SP & AF designed experiments and wrote the manuscript, B-SP analyzed
the data, MES and AR counseled the patients and the healthy siblings,
collected the biomaterials and provided the clinical data, BS and IT
generated the figures, RR performed CNV analyses for exomes, PR and SS
contributed to supervising the study, AF coordinated the project. All authors
discussed the results and commented on the manuscript. All authors read
and approved the final manuscript.
Acknowledgements
This work was in part supported by the DFG Cluster of Excellence
“Inflammation at Interfaces” and received funding under the EU Seventh
Framework Programme [FP7/2007-2013, grant number 262055, ESGI]. The
authors would like to thank Melanie Friskovec, Catharina von der Lancken,
Sandra Greve, Tanja Henke, Stefanie Arndt, Dorina Ölsner and Ilona Urbach
for technical assistance and the twins for taking part in this study.
Author details
1Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel,
Schittenhelmstrasse 12, 24105 Kiel, Germany. 2Department of Internal
Medicine, University Hospital Schleswig-Holstein, Kiel, Germany. 3Department
of Internal Medicine II, Gastroenterology, Asklepios Westklinikum Hamburg,
Hamburg, Germany. 4Genomics and Disease Group, Center for Genomic
Regulation, Barcelona, Spain.
Received: 25 April 2014 Accepted: 27 June 2014
Published: 5 July 2014
References
1. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC,
Schumm LP, Sharma Y, Anderson CA, Essers J, Mitrovic M, Ning K, Cleynen I,
Theatre E, Spain SL, Raychaudhuri S, Goyette P, Wei Z, Abraham C, Achkar J-P,
Ahmad T, Amininejad L, Ananthakrishnan AN, Andersen V, Andrews JM,
Baidoo L, Balschun T, Bampton PA, Bitton A, et al: Host-microbe interactions
have shaped the genetic architecture of inflammatory bowel disease. Nature
2012, 491:119–124.
2. Glocker E-O, Frede N, Perro M, Sebire N, Elawad M, Shah N, Grimbacher B:
Infant colitis–it’s in the genes. Lancet 2010, 376:1272.
3. Glocker E-O, Kotlarz D, Boztug K, Gertz EM, Schäffer A a, Noyan F, Perro M,
Diestelhorst J, Allroth A, Murugan D, Hätscher N, Pfeifer D, Sykora K-W,
Sauer M, Kreipe H, Lacher M, Nustede R, Woellner C, Baumann U, Salzer U,
Koletzko S, Shah N, Segal AW, Sauerbrey A, Buderus S, Snapper SB,
Grimbacher B, Klein C: Inflammatory bowel disease and mutations
affecting the interleukin-10 receptor. N Engl J Med 2009, 361:2033–2045.
4. Worthey E a, Mayer AN, Syverson GD, Helbling D, Bonacci BB, Decker B,
Serpe JM, Dasu T, Tschannen MR, Veith RL, Basehore MJ, Broeckel U,Tomita-Mitchell A, Arca MJ, Casper JT, Margolis D a, Bick DP, Hessner MJ,
Routes JM, Verbsky JW, Jacob HJ, Dimmock DP: Making a definitive
diagnosis: successful clinical application of whole exome sequencing in a
child with intractable inflammatory bowel disease. Genet Med 2011,
13:255–262.
5. Zeissig Y, Petersen B-S, Milutinovic S, Bosse E, Mayr G, Peuker K, Hartwig J,
Keller A, Kohl M, Laass MW, Billmann-Born S, Brandau H, Feller AC, Röcken C,
Schrappe M, Rosenstiel P, Reed JC, Schreiber S, Franke A, Zeissig S:
XIAP variants in male Crohn’s disease. Gut 2014. Epub ahead of print.
6. Spehlmann ME, Begun AZ, Saroglou E, Hinrichs F, Tiemann U, Raedler A,
Schreiber S: Risk factors in German twins with inflammatory bowel
disease: results of a questionnaire-based survey. J Crohns Colitis 2012,
6:29–42.
7. Häsler R, Feng Z, Bäckdahl L, Spehlmann ME, Franke A, Teschendorff A,
Rakyan VK, Down TA, Wilson G a, Feber A, Beck S, Schreiber S, Rosenstiel P:
A functional methylome map of ulcerative colitis. Genome Res 2012,
22:2130–2137.
8. Lepage P, Häsler R, Spehlmann ME, Rehman A, Zvirbliene A, Begun A, Ott S,
Kupcinskas L, Doré J, Raedler A, Schreiber S: Twin study indicates loss of
interaction between Microbiota and Mucosa of patients With Ulcerative
Colitis. Gastroenterology 2011, 141:227–236.
9. Silva S, Martins Y, Matias A, Blickstein I: Why are monozygotic twins
different? J Perinat Med 2011, 39:195–202.
10. Youssoufian H, Pyeritz RE: Mechanisms and consequences of somatic
mosaicism in humans. Nat Rev Genet 2002, 3:748–758.
11. Nieuwint A, Van Zalen-Sprock R, Hummel P, Pals G, Van Vugt J, Van Der
Harten H, Heins Y, Madan K: “Identical” twins with discordant karyotypes.
Prenat Diagn 1999, 19:72–76.
12. Kondo S, Schutte BC, Richardson RJ, Bjork BC, Knight AS, Watanabe Y,
Howard E, de Lima RLLF, Daack-Hirsch S, Sander A, McDonald-McGinn DM,
Zackai EH, Lammer EJ, Aylsworth AS, Ardinger HH, Lidral AC, Pober BR,
Moreno L, Arcos-Burgos M, Valencia C, Houdayer C, Bahuau M,
Moretti-Ferreira D, Richieri-Costa A, Dixon MJ, Murray JC: Mutations in
IRF6 cause Van der Woude and popliteal pterygium syndromes. Nat Genet
2002, 32:285–289.
13. Bruder CEG, Piotrowski A, Gijsbers AACJ, Andersson R, Erickson S, Diazde Ståhl T,
Menzel U, Sandgren J, von Tell D, Poplawski A, Crowley M, Crasto C,
Partridge EC, Tiwari H, Allison DB, Komorowski J, van Ommen G-JB,
Boomsma DI, Pedersen NL, den Dunnen JT, Wirdefeldt K, Dumanski JP:
Phenotypically concordant and discordant monozygotic twins display
different DNA copy-number-variation profiles. Am J Hum Genet 2008,
82:763–771.
14. Mansilla MA, Kimani J, Mitchell LE, Christensen K, Boomsma DI, Daack-Hirsch S,
Nepomucena B, Wyszynski DF, Felix TM, Martin NG, Murray JC: Discordant MZ
twins with cleft lip and palate: a model for identifying genes in complex
traits. Twin Res Hum Genet 2005, 8:39–46.
15. Roach JC, Glusman G, Smit AF a, Huff CD, Hubley R, Shannon PT, Rowen L,
Pant KP, Goodman N, Bamshad M, Shendure J, Drmanac R, Jorde LB,
Hood L, Galas DJ: Analysis of genetic inheritance in a family quartet
by whole-genome sequencing. Science 2010, 328:636–639.
16. Nachman MW, Crowell SL: Estimate of the mutation rate per nucleotide
in humans. Genetics 2000, 156:297–304.
17. Baranzini SE, Mudge J, van Velkinburgh JC, Khankhanian P, Khrebtukova I,
Miller N a, Zhang L, Farmer AD, Bell CJ, Kim RW, May GD, Woodward JE,
Caillier SJ, McElroy JP, Gomez R, Pando MJ, Clendenen LE, Ganusova EE,
Schilkey FD, Ramaraj T, Khan O a, Huntley JJ, Luo S, Kwok P-Y, Wu TD,
Schroth GP, Oksenberg JR, Hauser SL, Kingsmore SF: Genome, epigenome
and RNA sequences of monozygotic twins discordant for multiple
sclerosis. Nature 2010, 464:1351–1356.
18. Spehlmann ME, Begun AZ, Burghardt J, Lepage P, Raedler A, Schreiber S:
Epidemiology of inflammatory bowel disease in a German twin cohort:
results of a nationwide study. Inflamm Bowel Dis 2008, 14:968–976.
19. Bentley DR, Balasubramanian S, Swerdlow HP, Smith GP, Milton J, Brown CG,
Hall KP, Evers DJ, Barnes CL, Bignell HR, Boutell JM, Bryant J, Carter RJ, Keira
Cheetham R, Cox AJ, Ellis DJ, Flatbush MR, Gormley N a, Humphray SJ,
Irving LJ, Karbelashvili MS, Kirk SM, Li H, Liu X, Maisinger KS, Murray LJ,
Obradovic B, Ost T, Parkinson ML, Pratt MR, et al: Accurate whole human
genome sequencing using reversible terminator chemistry. Nature
2008, 456:53–59.
20. Jorde LB, Wooding SP: Genetic variation, classification and “race”. Nat Genet
2004, 36(11 Suppl):S28–S33.
Petersen et al. BMC Genomics 2014, 15:564 Page 11 of 11
http://www.biomedcentral.com/1471-2164/15/56421. 1000 Genomes Project Consortium T: A map of human genome variation
from population-scale sequencing. Nature 2010, 467:1061–1073.
22. Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE,
Kang HM, Marth GT, McVean GA: An integrated map of genetic variation
from 1,092 human genomes. Nature 2012, 491:56–65.
23. Kumar P, Henikoff S, Ng PC: Predicting the effects of coding non-
synonymous variants on protein function using the SIFT algorithm.
Nat Protoc 2009, 4:1073–1081.
24. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P,
Kondrashov AS, Sunyaev SR: A method and server for predicting
damaging missense mutations. Nat Methods 2010, 7:248–249.
25. Botstein D, Risch N: Discovering genotypes underlying human phenotypes:
past successes for mendelian disease, future approaches for complex
disease. Nat Genet 2003, 33(Suppl):228–237.
26. Gilissen C, Hoischen A, Brunner HG, Veltman JA: Disease gene
identification strategies for exome sequencing. Eur J Hum Genet 2012,
20:490–497.
27. MacArthur DG, Tyler-Smith C: Loss-of-function variants in the genomes of
healthy humans. Hum Mol Genet 2010, 19:R125–R130.
28. Larson DE, Harris CC, Chen K, Koboldt DC, Abbott TE, Dooling DJ, Ley TJ,
Mardis ER, Wilson RK, Ding L: SomaticSniper: identification of somatic
point mutations in whole genome sequencing data. Bioinformatics 2012,
28:311–317.
29. Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L, Miller CA,
Mardis ER, Ding L, Wilson RK: VarScan 2: Somatic mutation and copy
number alteration discovery in cancer by exome sequencing. Genome
Res 2012, 22:568–576.
30. Forster M, Forster P, Elsharawy A, Hemmrich G, Kreck B, Wittig M, Thomsen I,
Stade B, Barann M, Ellinghaus D, Petersen B-S, May S, Melum E, Schilhabel MB,
Keller A, Schreiber S, Rosenstiel P, Franke A: From next-generation sequencing
alignments to accurate comparison and validation of single-nucleotide
variants: the pibase software. Nucleic Acids Res 2012, 41:e16.
31. Rashid M, Robles-Espinoza CD, Rust AG, Adams DJ: Cake: a bioinformatics
pipeline for the integrated analysis of somatic variants in cancer genomes.
Bioinformatics 2013, 29:2208–2210.
32. Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, Getz G,
Mesirov JP: Integrative genomics viewer. Nat Biotechnol 2011, 29:24–26.
33. Eberwine J, Sul J-Y, Bartfai T, Kim J: The promise of single-cell sequencing.
Nat Methods 2013, 11:25–27.
34. Krawczak M, Cooper DN, Fändrich F, Engel W, Schmidtke J: How to
distinguish genetically between an alleged father and his monozygotic
twin: a thought experiment. Forensic Sci Int Genet 2012, 6:e129–e130.
35. Weber-Lehmann J, Schilling E, Gradl G, Richter DC, Wiehler J, Rolf B: Finding
the needle in the haystack: Differentiating “identical” twins in paternity
testing and forensics by ultra-deep next generation sequencing. Forensic
Sci Int Genet 2014, 9:42–46.
36. Gervin K, Vigeland MD, Mattingsdal M, Hammerø M, Nygård H, Olsen AO,
Brandt I, Harris JR, Undlien DE, Lyle R: DNA methylation and gene
expression changes in monozygotic twins discordant for psoriasis:
identification of epigenetically dysregulated genes. PLoS Genet 2012,
8:e1002454.
37. Li H, Durbin R: Fast and accurate short read alignment with Burrows-
Wheeler transform. Bioinformatics 2009, 25:1754–1760.
38. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis
G, Durbin R: The Sequence Alignment/Map format and SAMtools.
Bioinformatics 2009, 25:2078–2079.
39. Quinlan AR, Hall IM: BEDTools: a flexible suite of utilities for comparing
genomic features. Bioinformatics 2010, 26:841–842.
40. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A,
Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA: The Genome
Analysis Toolkit: a MapReduce framework for analyzing next-generation
DNA sequencing data. Genome Res 2010, 20:1297–1303.
41. Yoon S, Xuan Z, Makarov V, Ye K, Sebat J: Sensitive and accurate detection
of copy number variants using read depth of coverage. Genome Res
2009, 19:1586–1592.
42. Karolchik D, Hinrichs AS, Furey TS, Roskin KM, Sugnet CW, Haussler D,
Kent WJ: The UCSC Table Browser data retrieval tool. Nucleic Acids
Res 2004, 32(Database issue):D493–D496.
43. Macdonald JR, Ziman R, Yuen RKC, Feuk L, Scherer SW: The Database of
Genomic Variants: a curated collection of structural variation in the
human genome. Nucleic Acids Res 2014, 42:D986–D992.44. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J,
Sklar P, de Bakker PIW, Daly MJ, Sham PC: PLINK: a tool set for whole-genome
association and population-based linkage analyses. Am J Hum Genet 2007,
81:559–575.
45. R Development Core Team: R: A language and environment for statistical
computing. Vienna, Austria: R Foundation for Statistical Computing; 2008.
URL http://www.R-project.org. ISBN ISBN 3-900051-07-0.
doi:10.1186/1471-2164-15-564
Cite this article as: Petersen et al.: Whole genome and exome
sequencing of monozygotic twins discordant for Crohn’s disease. BMC
Genomics 2014 15:564.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
